publication venue for
- USE OF A CLINICAL DECISION SUPPORT SYSTEM TO MONITOR AND MANAGE PATIENTS AT HIGH RISK FOR CLOSTRIDIUM DIFFICILE INFECTIONS. 156:A1616-A1616. 2019
- INCIDENCE OF NEGATIVE URINE CULTURES AND ANTIBIOTIC USE WITH A URINALYSIS CULTURE SCREEN AND REFLEX ALGORITHM. 155:248A-248A. 2019
- PHARMACOECONOMIC IMPACT OF URINALYSIS CULTURE SCREEN AND REFLEX ALGORITHM ON ANTIMICROBIAL THERAPY. 155:250A-250A. 2019
- EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN MORBIDLY OBESE PATIENTS. 154:108A-108A. 2018
- EVALUATION OF SUGAMMADEX VS NEOSTIGMINE IN THE REVERSAL OF NEUROMUSCULAR BLOCKADE. 154:890A-890A. 2018
- VERIGENE GRAM-POSITIVE BLOOD CULTURE TESTING: CLINICAL AND PHARMACOECONOMIC IMPACT. 154:835A-835A. 2018
- Antimicrobial Therapy for Pneumonia: Role of Brain Natriuretic Peptide and Left Ventricular Ejection Fraction. 152:A125-A125. 2017
- Role of Ramsay Sedation Scale in Sedative Dosage Modulation for Critically-Ill Intubated Patients. 152:A330-A330. 2017
- P225 Evaluation of antimicrobial therapy in the ICU - fluid overload or pneumonia?. 151:A124-A124. 2017
- Management of Bronchopleural Fistula With the Nutritional Supplement-Juven, Vitamins A, and C, Zinc Gluconate, and Folic Acid. 150:567A-567A. 2016
- Real Time Applied Therapeutics in the Critical Care Environment: Role of a Data Mining Clinical Decision Support Tool. 150:226A-226A. 2016
- Use of a Data Mining Clinical Decision Support Tool to Optimize Pharmaceutical Care. 149:A237-A237. 2016
- Good, Bad, and Ugly on Vaping. 148:385A-385A. 2015
- Evaluation of the Use of Peripheral Parenteral Nutrition Therapy at a Community Institution. 140:281A-281A. 2011
- Azithromycin attenuates airway inflammation in a noninfectious mouse model of allergic asthma.. 136:498-506. 2009
- Airway inflammation in cystic fibrosis.. 133:489-495. 2008
- Predictors of rehospitalization and death after a severe exacerbation of COPD.. 132:1748-1755. 2007
- Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis.. 131:1718-1725. 2007
- A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis.. 127:308-317. 2005
- Improved myocardial function using a Na+/H+ exchanger inhibitor during cardioplegic arrest and cardiopulmonary bypass.. 123:187-194. 2003
- Exhaled nitric oxide during exercise in primary pulmonary hypertension and pulmonary fibrosis.. 111:44-50. 1997
- Diagnosis of cardiac sarcoidosis aided by MRI.. 110:562-565. 1996
- Contribution of the respiratory muscles to the lactic acidosis of heavy exercise in COPD.. 108:1246-1251. 1995
- Effect of cis-4-hydroxy-L-proline on lung mechanics and collagen content of bleomycin-treated hamsters.. 80:49-50. 1981
- Effect of Cis-4- hydroxy-L-proline on lung mechanics and collagen content of bleomycin-treated hamsters. 80:49S-50S. 1981
- PREVALENCE OF USE OF LAMA LABA REGIMEN USE FOR MANAGEMENT OF COPD IN REAL WORLD PRIMARY CARE SETTING 2019
- P242 Concurrent validity of sequential organ failure assessment versus systemic inflammatory response syndrome score for patients in the intensive care unit. 2017
- P243 Reliability and utility of the Ramsay sedation scale for dosing sedatives in critically ill intubated patients 2017
- Antibiotic Stewardship in Small Community Hospital 2014